The defining structural change in nephrology and dialysis is the turn from a plateau to gradual decline in patient numbers. Per the Japanese Society for Dialysis Therapy's annual survey, Japan's chronic dialysis population stood at about 337,414 at the end of 2024 — down 6,094 from the prior year and declining for a third consecutive year.
Dialysis patient numbers appear to have entered decline after peaking around 2021, and the government has set reducing new dialysis initiations as a policy goal. The era of patients arriving without effort is over; this is now a mature, contracting market where facilities compete for a limited population.
1. Macro environment — declining patients, ageing, and eroding fees at once
Patient ageing advances simultaneously. At the end of 2024, the average age of the year-end patient population was 70.27, and of newly initiated patients 71.69 — meaning patients now cross 70 at the point of initiation. Ageing raises travel burden (increasing transport demand), complicates frailty and comorbidity management, and affects chair turnover.
Diabetic nephropathy has long been the leading cause (39.5% at the end of 2022), with nephrosclerosis rising against the backdrop of ageing. The inseparability of nephrology from lifestyle disease management is clear.
On fees, the FY2026 revision cut base points for chronic maintenance dialysis (J038) by a uniform 20 points across all categories, while creating a "renal replacement therapy readiness add-on" (20 points per day), per multiple secondary sources.
| Category (chronic maintenance dialysis 1) | Reiwa 6 | Reiwa 8 | Change |
|---|---|---|---|
| Under 4 hours | 1,876 | 1,856 | −20 |
| 4 to under 5 hours | 2,036 | 2,016 | −20 |
| 5 hours or more | 2,171 | 2,151 | −20 |
One simulation puts the impact at roughly −¥260,000 monthly and −¥3.12 million annually for a 100-patient facility. Base fee erosion is a continuing trend, and the structure of offsetting it through add-on capture has become sharper.
2. Characteristics of newly opened clinics
The defining feature is exceptionally heavy capital investment. Even tenant-based openings run to ¥100 million because of ultrapure water systems and specialized plumbing, and a 40-chair facility with land acquisition is estimated at ¥300 million. Floor area demands are large — an additional 130 m² for 20 chairs, 200 m² for 40 — so location and rent heavily determine break-even.
Revenue is essentially unit price × patients × sessions, and with three sessions weekly, four hours each, roughly twelve visits monthly as the standard, securing a stable patient base is an absolute condition of viability. Physician income ranges from ¥20 million to over ¥40 million depending on practice form, though reaching that level in the early stage is described as difficult.
A pronounced recent trend is the shift in advantage from single-site to multi-site chain operation. Under the triple squeeze of suppressed fees, rising personnel and material costs, and declining patients, single clinics face structural disadvantages:
- Difficulty achieving scale in joint purchasing of dialyzers and drugs
- No flexibility in staffing across sites
- No training infrastructure, forcing high-wage hiring of experienced staff
Chains gain advantage through centralized purchasing, cross-site staffing flexibility, personnel cost control through training, and back-office consolidation. For new entrants, joining a group or securing scale through M&A or succession is increasingly the realistic option over a standalone practice.
On acquisition, the essentials are assessing the patient population and competition within a 10–20 km radius and building referral routes from core hospitals, nephrology, and urology departments, with an emphasis on spacious, low-rent tenants near stations. Beyond that, quality-of-life investments to prevent transfers — reclining chairs, free TV and Wi-Fi, transport services — function as differentiators in a shrinking market.
3. Revenue areas specific to nephrology
Revenue is built by stacking management, procedures, and coordination around the pillar of maintenance dialysis.
CKD progression prevention and pre-referral management
The chronic kidney disease dialysis prevention guidance management fee, created in the FY2024 revision, covers pre-dialysis CKD patients (excluding those with diabetes or on dialysis), with a multidisciplinary team of physician, nurse, and registered dietitian providing salt and protein restriction and exercise guidance. Secondary sources cite 300 points within the first year and 250 points thereafter (261 and 218 respectively when using telecommunications).
Eligibility covers a defined range of CKD stages G3a–G5, with experience requirements including five years for the dedicated physician, three for the nurse, and three for the dietitian. It aligns with policy to delay dialysis initiation and institutionally supports the revenue opportunity of pre-dialysis outpatient nephrology — but billing presupposes a multidisciplinary structure.
Maintenance dialysis — the pillar, and its erosion
Base points keep eroding while total revenue is set by time category, patient count, and session frequency, making utilization (chair turnover) and patient retention existential.
The new renal replacement therapy readiness add-on (20 points per day) reportedly comprises four requirements (some with transitional measures):
- A patient explanation framework documenting all three options — hemodialysis, peritoneal dialysis, and transplantation — in the medical record
- A track record of PD billing or transplant procedures
- A coordination framework for vascular access management and repair
- A disaster response manual and participation in drills
The design offsets the base fee cut through add-on capture, meaning nephrology's full capability set — therapy option counseling, bridging to PD and transplant, disaster preparedness, vascular access coordination — is directly the billing requirement, and therefore the revenue.
Vascular access management
Access is the lifeline of dialysis, and percutaneous angioplasty (VAIVT) for stenosis and occlusion carries high clinical importance, with more facilities operating specialty clinics or vascular access centers for both function and revenue. Secondary sources report tightened VAIVT billing requirements in FY2026 (criteria including flow volume and resistance index), demanding more evidence-based indication. Access coordination is also a requirement of the readiness add-on, so whether to handle it in-house or partner with nearby specialists is a management decision.
Coordination with diabetic nephropathy
With diabetic nephropathy as the leading cause, coordination with diabetes practices and primary care physicians is essential. The Diabetic Nephropathy Progression Prevention Program promoted by municipalities, medical associations, and MHLW reduces dialysis initiation through high-risk identification from checkup data, visit encouragement, and health guidance — positioning nephrologists as the receiving point for referrals and back-referrals. Building the referral network serves both patient acquisition and progression prevention.
Home and peritoneal dialysis, ageing, and transport
PD and home hemodialysis are expected to grow for reasons of travel burden, patient quality of life, differentiation, and the readiness add-on requirements. But PD demands specialized expertise and effort to initiate and manage, and case volumes are limited — so it is better understood as breadth of therapy options, an add-on requirement, and regional coordination value than as a revenue pillar.
With average age at initiation above 70, transport services are becoming an effectively mandatory service tied directly to visit continuity and retention. Transport is a cost driver and simultaneously a differentiation and retention mechanism.
4. Self-pay services — structurally limited
In contrast to aesthetic specialties, self-pay headroom is structurally limited in nephrology and dialysis.
The reason is clear: maintenance dialysis is heavily subsidized through high-cost medical expense benefits, the self-support medical care system, and the specific chronic disease benefit, keeping actual patient out-of-pocket costs to roughly ¥10,000 monthly. There is little room or need to charge above that, and a business model centered on self-pay revenue simply does not work.
The realistic position for uninsured value-add is amenity investment for patient satisfaction and retention rather than revenue: private rooms, reclining chairs, free TV and Wi-Fi, meals, transport. Most are provided free or at cost, contributing indirectly through transfer prevention and referral reputation rather than as direct revenue.
Note that foot care for diabetic lower-limb complications and access-related foot care is often mistaken for self-pay, when in fact it is evaluated within insured care through the diabetes complication management fee and peripheral arterial disease guidance add-on — best approached as enriched insured management rather than self-pay.
5. Management implications
First, this is a mature, contracting market built on insured maintenance dialysis, with declining patients, ageing, and eroding base fees advancing together. The battleground is holding revenue through utilization, retention, add-on capture, and coordination rather than raising unit price.
Second, the "base down, readiness add-on up" structure revealed in FY2026 institutionally evaluates and demands nephrology's full capability set — therapy option counseling, bridging to PD and transplant, access coordination, disaster preparedness. These are not billing techniques but the substance of being chosen by patients and attracting referrals; building toward the add-on requirements is strengthening the operating base.
Third, the shift from standalone to chain and group operation is clear on efficiency grounds, with joint purchasing, staffing flexibility, training, and back-office consolidation widening the gap.
Fourth, strengthening CKD progression prevention, diabetic nephropathy coordination, and referral relationships with primary care builds the pre-dialysis outpatient nephrology function for both revenue and brand, securing the long-term patient pipeline.
Fifth, self-pay cannot be the revenue core. Excessive expectations are misplaced; comfort, transport, and amenities should be designed as indirect returns through retention and referral.
6. How an AI EMR addresses these problems — feature by feature
In a dialysis clinic, records pile up three times a week for every patient: dialysis parameters, weight and ultrafiltration volume, vitals, lab values, access findings. Now that base points have fallen and add-ons must make up the difference, those records are the evidence behind your billing. Here is how Pottech's AI Karte supports that, feature by feature.
Feature 1: Billing and claims — add-on capture is the only way to close the gap
An automated calculation engine checks bundling conflicts, exclusions, and frequency limits, and determines eligibility automatically.
With base points cut by a uniform 20, reliable add-on capture is the only mechanism to close the revenue gap. The renal replacement therapy readiness add-on (20 points per day) is billed daily per patient, so any patient failing the requirements compounds into lost revenue. Because dialysis bills at high frequency — three sessions weekly, twelve monthly — small per-case losses become large annual amounts. Adapting to the tightened VAIVT requirements has the same structure.
Feature 2: Charting and orders — standardize the records that satisfy add-on requirements
AI generates SOAP notes from consultation audio, with template registration and recall.
The first requirement of the readiness add-on is a patient explanation framework documenting all three therapy options in the medical record. The requirement is not that you explained but that it is recorded. Likewise, the CKD dialysis prevention guidance fee includes documentation of guidance plans and risk assessment, and the disaster manual and drill participation must be recorded. Meeting billing requirements demands documentation, not just delivery, so standardizing record templates directly prevents revenue loss.
Feature 3: Integrations and APIs — connect dialysis system data to the chart
An OAuth2 gateway, MCP server, and HAPI FHIR enable integration with external systems.
Electronic recording of dialysis parameters and session records through dialysis support systems is already standard. But when disconnected from the chart, physicians, nurses, clinical engineers, and dietitians each record into different systems, scattering the information that proves add-on compliance. Whether multidisciplinary records can be unified determines the cost of demonstrating compliance.
Feature 4: AI assistant — surface high-risk patients from lab trends
Summarizes lab value trends and personalizes patient-facing explanations.
CKD progression prevention starts with identifying high-risk patients early from eGFR decline rate, proteinuria, and blood pressure trajectory. In building the pre-dialysis outpatient nephrology function, extraction from lab trends is the patient pipeline itself. For dialysis patients, summarizing weight gain rates, ultrafiltration volumes, anemia, and bone mineral metabolism indicators over time raises the quality of multidisciplinary conferences.
Feature 5: Document generation — sustain the referral network
AI drafts referral letters and clinical information provision documents from patient data.
The Diabetic Nephropathy Progression Prevention Program runs on a round trip of referral from primary care and back-referral from nephrologists. The same applies to partnering on access repair with nearby specialists. The higher the round-trip frequency, the more document cost constrains actual coordination volume. In a shrinking market where securing the patient pipeline is essential, making that round trip cheap has direct business impact.
Feature 6: Practice analytics — track chair utilization and add-on capture
Visit volume, revenue per patient, and monthly trends are aggregated and visualized automatically.
Since revenue is essentially unit price × patients × sessions, chair utilization is the primary operating metric. With base fees cut and add-ons compensating, add-on capture rate — what share of eligible patients you actually billed for — joins it as a new metric. Part of why chains gain advantage is their ability to compare and improve these metrics across sites. A standalone facility that can follow them monthly gains the same improvement cycle.
Primary sources
- Japanese Society for Dialysis Therapy, "Current status of chronic dialysis therapy in Japan," 2024 summary https://docs.jsdt.or.jp/overview/file/2024/pdf/conclusion.pdf
- Japan Association for Prevention of Lifestyle-Related Diseases (cause distribution) https://www.seikatsusyukanbyo.com/statistics/2024/010782.php
- MHLW, "Diabetic Nephropathy Progression Prevention Program" https://www.mhlw.go.jp/file/04-Houdouhappyou-12401000-Hokenkyoku-Soumuka/0000121902.pdf
- Jimucho.net, "FY2026 revision: dialysis practice implications" https://jimu-cho.net/26646/
- Dialysis CE Practice Notes, "2026 revision: fee comparison, readiness add-on, VAIVT requirements" https://dialysis-dad-life.blog/medical-fee-revision-2026-dialysis/
- Credo Medical, "CKD dialysis prevention guidance management fee" https://www.credo-m.co.jp/column/detail/hosyu/15537/
- Wemex/Medicom, "Opening a dialysis practice: capital, income, revenue structure" https://www.phchd.com/jp/medicom/park/idea/opening-dialysis
- Mediva, "Dialysis patient acquisition and population trends" https://mediva.co.jp/report/consultant-blog/2980/